The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO 2016 | Somatic genomic landscape of advanced-stage cancer patients from clinical NGS analysis of ctDNA

Name: Somatic genomic landscape of advanced-stage cancer patients from clinical NGS analysis of ctDNA
Uploaded: 2016-06-03T00:00:00.000Z
Duration: 5 min 33 s
Description: Press brief by Philip Mack, PhD of the UC Davis Comprehensive Cancer Center, Sacramento, CA, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

Philip Mack • 3 Jun 2016

ASCO 2016

Breast Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecological Cancer Lung Cancer Skin Cancer

Press brief by Philip Mack, PhD of the UC Davis Comprehensive Cancer Center, Sacramento, CA, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

ASCO 2016 | Somatic genomic landscape of advanced-stage cancer patients from clinical NGS analysis of ctDNA

Related Videos

Cookie settings